A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing

DOI: 10.1128/JCM.01123-16

Article Information

DOI

PubMed

Published By

History

Editors and / or Reviewers

^aJanssen Research & Development, LLC, Titusville, New Jersey, USA
^bIRCCS, San Raffaele Scientific Institute, Milan, Italy
^cTB Supranational Reference Laboratory, The Public Health Agency of Sweden, Solna, Sweden
^dNational TB Reference Laboratory, Center for Tuberculosis, National Institute of Communicable Diseases, Johannesburg, South Africa
^eDepartment of Medical Microbiology, University of Pretoria, Pretoria, South Africa
^fUniversity of Massachusetts Medical School, Massachusetts Supranational TB Reference Laboratory, Boston, Massachusetts, USA
^gJanssen Pharmaceutica NV, Beerse, Belgium
^hReference Laboratory, Division of TB Elimination, United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA
ⁱDepartment of Medical Microbiology, Center of Laboratory Medicine, Luzerner Kantonsspital LUKS, Luzern, Switzerland
^jTASK Applied Science, SA MRC Centre for TB Research, DST/NRF Center of Excellence for Biomedical TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa

Address correspondence to Koné Kaniga, kkaniga{at}its.jnj.com.
Citation Kaniga K, Cirillo DM, Hoffner S, Ismail NA, Kaur D, Lounis N, Metchock B, Pfyffer GE, Venter A. 2016. A multilaboratory, multicountry study to determine bedaquiline MIC quality control ranges for phenotypic drug susceptibility testing. J Clin Microbiol 54:2956–2962. doi:10.1128/JCM.01123-16.

Rendering graph...